Fortis Malar Hospitals share price
You have to be logged in to add this to Watchlist.- ₹86.00(0.61%)April 21, 2025 15:29:51 PM IST
- NSE
- BSE
- Vol : 71.65K (NSE + BSE)Last 20 day avg : 96.55 K
Fortis Malar Hospitals is trading 0.61% upper at Rs 86.00 as compared to its last closing price. Fortis Malar Hospitals has been trading in the price range of 86.90 & 84.25. Fortis Malar Hospitals has given 41.48% in this year & -0.09% in the last 5 days. Fortis Malar Hospitals has TTM P/E ratio 2.10 as compared to the sector P/E of 23.09.The company posted a net profit of 0.01 Crores in its last quarter.Listed peers of Fortis Malar Hospitals include Kerala Ayurveda (-1.32%), Aashka Hospitals (-%), Fortis Malar Hospitals (0.61%).The Mutual Fund holding in Fortis Malar Hospitals was at 0.07% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Fortis Malar Hospitals was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 21, 2025, 02:48 PM UTC
- Dividend YieldHigher than industry2.92Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.46The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values2.97Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.25Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The company's revenue fell during December quarter by 100.00% from Rs 17.58 crore to Rs 0.00 crore, year-on-year- Company has registered a profit of 0.01 cr vs a loss of 4.00 cr in the same quarter last year.
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 91.41
- R2
- 109.40
- R3
- 120.11
- S1
- 62.71
- S2
- 52.00
- S3
- 34.01
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Kerala Ayurveda | Bearish | 325.05 | -1.32 | 399.48 | - | 12.32 | - | 184.73 |
| Aashka Hospitals | Neutral | 105.90 | - | 247.81 | 104.96 | 2.57 | - | 8.59 |
| Fortis Malar Hospitals | Bullish | 86.00 | 0.61 | 160.78 | 20.88 | 1.46 | 49.72 | - |
| Lotus Eye Hospital And Institute | Moderately Bullish | 66.85 | 0.60 | 140.03 | 47.18 | 2.31 | - | 1.16 |
| Aspira Pathlab & Diagnostics | Neutral | 68.70 | 4.73 | 70.71 | - | 6.66 | - | 20.54 |
- Promoter(s) holds a high stake in the company at 62.71%
- FIIs are not invested in this company
- Mutual Funds holding is constant over the last quarter at 0.07%
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-03 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
| 2024-07-22 | Quarterly Results |
| 2024-05-17 | Audited Results |
| 2024-04-12 | Interim Dividend |
- IndustryHealthcare Facilities
- ISININE842B01015
- BSE Code523696
- NSE Code
Fortis Malar Hospitals is trading at 86.00 as on Mon Apr 21 2025 09:59:51. This is 0.61% upper as compared to its previous closing price of 85.48.
The market capitalization of Fortis Malar Hospitals is 160.78 Cr as on Mon Apr 21 2025 09:59:51.
The 52 wk high for Fortis Malar Hospitals is 107.94 whereas the 52 wk low is 51.01
Fortis Malar Hospitals can be analyzed on the following key metrics -
- TTM P/E: 2.10
- Sector P/E: 23.09
- Dividend Yield: 2.92%
- D/E ratio: -
Fortis Malar Hospitals reported a net profit of 45.32 Cr in 2024.
The Mutual Fund Shareholding was 0.07% at the end of 31 Mar 2025.